Ng William, Dai Jin-Rui, Slon-Usakiewicz Jacek J, Redden Peter R, Pasternak Andrew, Reid Neil
Transition Therapeutics Inc, Drug Discovery Group, Toronto, Ontario, Canada.
J Biomol Screen. 2007 Mar;12(2):167-74. doi: 10.1177/1087057106297567. Epub 2007 Jan 11.
High-throughput screening (HTS) efforts to discover "hits" typically rely on the large-scale parallel screening of individual compounds with attempts to screen mixtures of compounds typically and, unfortunately, giving rise to false positives and false negatives due to the nature of the HTS readout (% inhibition/activation above a defined threshold) that makes deconvolution virtually intractable. Bioaffinity screening methods have emerged as an alternative or orthogonal method to classic HTS. One of these methods, frontal affinity chromatography coupled to mass spectrometry detection (FAC-MS), although still a relatively new technique, is turning out to be a viable screening tool. However, to push FAC-MS more to the forefront as a moderate primary HTS system (or a secondary screening assay), automation needs to be addressed. An automated FAC-MS system is described using 2 columns containing immobilized hERbeta, whereby while 1 column is being regenerated, the other is being used. The authors are extrapolating that in a continuous 24-h operation, the number of ligands screened could potentially approach 10,000. In addition, preliminary structure-activity relationship binding information (typically not seen in early primary HTS) can be obtained by observing the rank order of the library members in the various mixtures.
高通量筛选(HTS)寻找“命中”化合物的工作通常依赖于对单个化合物进行大规模平行筛选,一般不会尝试筛选化合物混合物,不幸的是,由于HTS读数(高于定义阈值的抑制/激活百分比)的性质,会产生假阳性和假阴性,这使得反卷积几乎难以处理。生物亲和筛选方法已成为经典HTS的替代或正交方法。其中一种方法,即与质谱检测联用的前沿亲和色谱法(FAC-MS),尽管仍是一项相对较新的技术,但正成为一种可行的筛选工具。然而,要将FAC-MS作为一种适度的一级HTS系统(或二级筛选分析方法)推向更前沿,就需要解决自动化问题。本文描述了一种自动化的FAC-MS系统,该系统使用两根装有固定化人雌激素受体β(hERbeta)的柱子,在一根柱子再生时,另一根柱子用于检测。作者推断,在连续24小时的操作中,筛选的配体数量可能接近10000个。此外,通过观察各种混合物中库成员的排序,可以获得初步的构效关系结合信息(这在早期的一级HTS中通常看不到)。